Brain Tumor Reports
48

Volume 17 Number 8
August 2017


Home > Publications > Brain Tumor Reports > Volume 17, Year 2017 > Number 8, August


CONTENTS



BRAIN TUMORS
DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS
-
Anaplastic astrocytoma
-
Glioblastoma
EPENDYMAL TUMORS
GLIOMAS
-
Brain stem gliomas
-
Low-grade gliomas
EMBRYONAL TUMORS
-
Medulloblastoma
LYMPHOMAS





BRAIN TUMORS



Brindle KM, Izquierdo-García JL, Lewis DY, Mair RJ, Wright AJ.
Brain Tumor Imaging.
J Clin Oncol. 2017 Jun 22:JCO2017727636. doi: 10.1200/JCO.2017.72.7636. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Mack SC, Northcott PA.
Genomic Analysis of Childhood Brain Tumors: Methods for Genome-Wide Discovery and Precision Medicine Become Mainstream.
J Clin Oncol. 2017 Jun 22:JCO2017729921. doi: 10.1200/JCO.2017.72.9921. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Mellinghoff IK, Gilbertson RJ.
Brain Tumors: Challenges and Opportunities to Cure.
J Clin Oncol. 2017 Jun 22:JCO2017742965. doi: 10.1200/JCO.2017.74.2965. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Parada LF, Dirks PB, Wechsler-Reya RJ.
Brain Tumor Stem Cells Remain in Play.
J Clin Oncol. 2017 Jun 22:JCO2017739540. doi: 10.1200/JCO.2017.73.9540. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Sampson JH, Maus MV, June CH.
Immunotherapy for Brain Tumors.
J Clin Oncol. 2017 Jun 22:JCO2017728089. doi: 10.1200/JCO.2017.72.8089. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Wen PY, Chang SM, Van den Bent MJ, Vogelbaum MA, Macdonald DR, Lee EQ.
Response Assessment in Neuro-Oncology Clinical Trials.
J Clin Oncol. 2017 Jun 22:JCO2017727511. doi: 10.1200/JCO.2017.72.7511. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS



van den Bent MJ, Smits M, Kros JM, Chang SM.
Diffuse Infiltrating Oligodendroglioma and Astrocytoma.
J Clin Oncol. 2017 Jun 22:JCO2017726737. doi: 10.1200/JCO.2017.72.6737. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




ANAPLASTIC ASTROCYTOMA


Malmström A, Poulsen HS, Grønberg BH, Stragliotto G, Hansen S, Asklund T, Holmlund B, Łysiak M, Dowsett J, Kristensen BW, Söderkvist P, Rosell J, Henriksson R; Nordic Clinical Brain Tumor Study Group (NCBTSG).
Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial.
Acta Oncol. 2017 Jul 4:1-10. doi: 10.1080/0284186X.2017.1332780. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




GLIOBLASTOMA


Alexander BM, Cloughesy TF.
Adult Glioblastoma.
J Clin Oncol. 2017 Jun 22:JCO2017730119. doi: 10.1200/JCO.2017.73.0119. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Bhandari M, Gandhi AK, Devnani B, Kumar P, Sharma DN, Julka PK.
Comparative Study of Adjuvant Temozolomide Six Cycles Versus Extended 12 Cycles in Newly Diagnosed Glioblastoma Multiforme.
J Clin Diagn Res. 2017 May;11(5):XC04-XC08. doi: 10.7860/JCDR/2017/27611.9945. Epub 2017 May 1.
Source | Abstract | Full text | Similar articles




Darmon I, Morisse MC, Coutte A, Blonski M, Rhun EL, Taillandier L, Roufai DB, Desenclos C, Trudel S, Faivre JC, Blanchard N, Chauffert B, Boone M.
Temozolomide and Bevacizumab Induction before Chemoradiotherapy in Patients with Bulky Glioblastoma and/or with Severe Neurological Impairment.
J Cancer. 2017 May 12;8(8):1417-1424. doi: 10.7150/jca.18339. eCollection 2017.
Source | Abstract | Full text | Similar articles




Fariselli L, Cuppini L, Gaviani P, Marchetti M, Pinzi V, Milanesi I, Simonetti G, Tramacere I, DiMeco F, Salmaggi A, Silvani A.
Short course radiotherapy concomitant with temozolomide in GBM patients: a phase II study.
Tumori. 2017 Jul 8:0. doi: 10.5301/tj.5000672. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Franceschi E, Minichillo S, Brandes AA.
Pharmacotherapy of Glioblastoma: Established Treatments and Emerging Concepts.
CNS Drugs. 2017 Jul 5. doi: 10.1007/s40263-017-0454-8. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Haque W, Verma V, Butler EB, Teh BS.
Definitive chemoradiation at high volume facilities is associated with improved survival in glioblastoma.
J Neurooncol. 2017 Jul 7. doi: 10.1007/s11060-017-2563-0. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Miller TE, Liau BB, Wallace LC, Morton AR, Xie Q, Dixit D, Factor DC, Kim LJY, Morrow JJ, Wu Q, Mack SC, Hubert CG, Gillespie SM, Flavahan WA, Hoffmann T, Thummalapalli R, Hemann MT, Paddison PJ, Horbinski CM, Zuber J, Scacheri PC, Bernstein BE, Tesar PJ, Rich JN.
Transcription elongation factors represent in vivo cancer dependencies in glioblastoma.
Nature. 2017 Jul 5. doi: 10.1038/nature23000. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Morgan E, Mason W.
What are the prospects for combination therapy for glioblastoma?
Expert Rev Neurother. 2017 Jul 12:1-3. doi: 10.1080/14737175.2017.1351300. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Mrugala MM, Ruzevick J, Zlomanczuk P, Lukas RV.
Tumor Treating Fields in Neuro-Oncological Practice.
Curr Oncol Rep. 2017 Aug;19(8):53. doi: 10.1007/s11912-017-0611-8.
Source | Abstract | Full text | Similar articles




Northcott PA.
Cancer: Keeping it real to kill glioblastoma.
Nature. 2017 Jul 5. doi: 10.1038/nature23095. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Sekerdag E, Lüle S, Bozdağ Pehlivan S, Öztürk N, Kara A, Kaffashi A, Vural I, Işıkay I, Yavuz B, Oguz KK, Söylemezoğlu F, Gürsoy-Özdemir Y, Mut M.
A potential non-invasive glioblastoma treatment: Nose-to-brain delivery of farnesylthiosalicylic acid incorporated hybrid nanoparticles.
J Control Release. 2017 Jul 3;261:187-198. doi: 10.1016/j.jconrel.2017.06.032. [Epub ahead of print] Accepted 2017 Jun 28.
Source | Abstract | Full text | Similar articles




Simonetti G, Silvani A, Fariselli L, Hottinger AF, Pesce GA, Prada F, Gaviani P.
Extra central nervous system metastases from glioblastoma: a new possible trigger event?
Neurol Sci. 2017 Jun 24. doi: 10.1007/s10072-017-3036-0. [Epub ahead of print]
Source | Abstract | Full text | Similar articles | Editor's choice




Straube C, Elpula G, Gempt J, Gerhardt J, Bette S, Zimmer C, Schmidt-Graf F, Meyer B, Combs SE.
Re-irradiation after gross total resection of recurrent glioblastoma : Spatial pattern of recurrence and a review of the literature as a basis for target volume definition.
Strahlenther Onkol. 2017 Jun 14. doi: 10.1007/s00066-017-1161-6. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Thippu Jayaprakash K, Wildschut K, Jena R.
Feasibility of Hippocampal Avoidance Radiotherapy for Glioblastoma.
Clin Oncol (R Coll Radiol). 2017 Jul 7. pii: S0936-6555(17)30285-6. doi: 10.1016/j.clon.2017.06.010. [Epub ahead of print] Accepted 2017 May 30.
Source | Abstract | Full text | Similar articles




Wenger KJ, Wagner M, You SJ, Franz K, Harter PN, Burger MC, Voss M, Ronellenfitsch MW, Fokas E, Steinbach JP, Bähr O.
Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustine.
Oncol Lett. 2017 Jul;14(1):1141-1146. doi: 10.3892/ol.2017.6251. Epub 2017 May 25.
Source | Abstract | Full text | Similar articles





EPENDYMAL TUMORS



Merchant TE.
Current Clinical Challenges in Childhood Ependymoma: A Focused Review.
J Clin Oncol. 2017 Jun 22:JCO2017731265. doi: 10.1200/JCO.2017.73.1265. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





GLIOMAS



Li Q, Guo J, Wang W, Wang D.
Relationship between MGMT gene expression and treatment effectiveness and prognosis in glioma.
Oncol Lett. 2017 Jul;14(1):229-233. doi: 10.3892/ol.2017.6123. Epub 2017 May 5.
Source | Abstract | Full text | Similar articles




Sturm D, Pfister SM, Jones DTW.
Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical Management.
J Clin Oncol. 2017 Jun 22:JCO2017730242. doi: 10.1200/JCO.2017.73.0242. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




BRAIN STEM GLIOMAS


Hassan H, Pinches A, Picton SV, Phillips RS.
Survival rates and prognostic predictors of high grade brain stem gliomas in childhood: a systematic review and meta-analysis.
J Neurooncol. 2017 Jul 5. doi: 10.1007/s11060-017-2546-1. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




LOW-GRADE GLIOMAS


Gnekow AK, Walker DA, Kandels D, Picton S, Giorgio Perilongo, Grill J, Stokland T, Sandstrom PE, Warmuth-Metz M, Pietsch T, Giangaspero F, Schmidt R, Faldum A, Kilmartin D, De Paoli A, De Salvo GL; of the Low Grade Glioma Consortium and the participating centers.
A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma - A final report.
Eur J Cancer. 2017 Aug;81:206-225. doi: 10.1016/j.ejca.2017.04.019. Epub 2017 Jun 22.
Source | Abstract | Full text | Similar articles





EMBRYONAL TUMORS



MEDULLOBLASTOMA


Ramaswamy V, Taylor MD.
Medulloblastoma: From Myth to Molecular.
J Clin Oncol. 2017 Jun 22:JCO2017727842. doi: 10.1200/JCO.2017.72.7842. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





LYMPHOMAS



Grommes C, DeAngelis LM.
Primary CNS Lymphoma.
J Clin Oncol. 2017 Jun 22:JCO2017727602. doi: 10.1200/JCO.2017.72.7602. [Epub ahead of print]
Source | Abstract | Full text | Similar articles